Home
Conditions
Solid Cancers

Clinical trial condition

Solid Cancers

Explore clinical trials studying Solid Cancers. Study availability and eligibility vary by location and protocol.

39 public trials 10 recruiting studies

Refine in advanced search Browse all conditions

Solid Cancers trial results

Completed

A Study to Assess the Safety and Tolerability of Atezolizumab in Combination With Other Immune-Modulating Therapies in Participants With Locally Advanced or Metastatic Solid Tumors

NCT02174172

Conditions: Solid Cancers
Locations: HonorHealth Research Institute - Bisgrove Scottsdale, Arizona, United States

Mayo Clinic- Scottsdale Scottsdale, Arizona, United States

UCLA Los Angeles, California, United States

Yale University New Haven, Connecticut, United States

View Trial Details

Completed

Phase I Assay-guided Trial of Anti-inflammatory Phytochemicals in Patients With Advanced Cancer

NCT01820299

Conditions: Solid Cancers
Locations: Medical University of South Carolina Charleston, South Carolina, United States

View Trial Details

Completed

A Study of Hedgehog Pathway Inhibitor GDC-0449 in Patients With Locally Advanced or Metastatic Solid Tumors That Are Refractory to Standard Therapy or for Whom No Standard Therapy Exists

NCT00968981

Conditions: Carcinoma, Carcinoma, Basal Cell, Neoplasms, +4 more
Locations: Not specified

View Trial Details

Completed

A Study of the Safety and Pharmacology of MetMAb (PRO143966), a Monovalent Antagonist Antibody to the Receptor C-Met, Administered Intravenously in Patients With Locally Advanced or Metastatic Solid Tumors

NCT01068977

Conditions: Solid Cancers
Locations: Not specified

View Trial Details

Completed

A Study of MNRP1685A in Combination With Bevacizumab With or Without Paclitaxel in Patients With Locally Advanced or Metastatic Solid Tumors

NCT00954642

Conditions: Solid Cancers
Locations: Not specified

View Trial Details

Completed

A Study of the Safety and Pharmacokinetics of MINT1526A, Administered Intravenously As a Single Agent and in Combination With Bevacizumab to Patients With Advanced Solid Tumors

NCT01139723

Conditions: Solid Cancers
Locations: Encinitas, California, United States

Los Angeles, California, United States

Aurora, Colorado, United States

View Trial Details

Completed

A Study of GDC-0941 in Participants With Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable

NCT00876109

Conditions: Solid Cancers
Locations: Scottsdale, Arizona, United States

Boston, Massachusetts, United States

Detroit, Michigan, United States

View Trial Details

Completed

A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0917 Administered to Patients With Refractory Solid Tumors or Lymphoma

NCT01226277

Conditions: Solid Cancers
Locations: Nashville, Tennessee, United States

San Antonio, Texas, United States

View Trial Details

Completed

A Study of the Safety and Pharmacology of GDC-0980 in Combination With Either Paclitaxel and Carboplatin (With or Without Bevacizumab) or Pemetrexed and Cisplatin in Patients With Solid Tumors

NCT01301716

Conditions: Solid Cancers
Locations: Los Angeles, California, United States

Tampa, Florida, United States

Boston, Massachusetts, United States

Boston, Massachusetts, United States

View Trial Details

Completed

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0623 in Patients With Locally Advanced or Metastatic Solid Tumors

NCT01106599

Conditions: Solid Cancers
Locations: Los Angeles, California, United States

Sacramento, California, United States

Oklahoma City, Oklahoma, United States

Nashville, Tennessee, United States

View Trial Details

Solid Cancers

Solid Cancers trial results

Related conditions